Cargando...
18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
BACKGROUND: (18)F‐florbetapir uptake by brain tissue measured by positron emission tomography (PET) is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly de...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2017
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486090/ https://ncbi.nlm.nih.gov/pubmed/29164603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012216.pub2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|